Skip to main content

Table 2 Patients’ OS variables and IVF cycle laboratory characteristics Pre/Post Covid-19 Vaccination

From: Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?

 

Pre Vaccination

Post Vaccination

P-value

Antagonist Protocol (%)

34/36 (94.4)

35/36 (97.2)

NS

Duration of stimulation (days)

10.7 ± 2.6

10.8 ± 2.2

NS

Total FSH dose used, IU (mean ± SD)

3802 ± 1956

3906 ± 1565

NS

Mean peak estradiol levels pmol/L (mean ± SD)

6041 ± 4052

7708 ± 7640

NS

Mean peak progesterone levels nmol/L (mean ± SD)

2.3 ± 1.8

2.2 ± 1.2

NS

Mean # of Oocytes per OPU (mean ± SD)

9.7 ± 6.7

10.1 ± 8

NS

Mean # of MII per OPU (mean ± SD)

7.94 ± 5.7

8.0 ± 6.5

NS

Mean # of MII / # of oocytes retrieved (mean ± SD)

0.83 ± 0.1

0.78 ± 0.2

NS

Mean # of 2PN per OPU (mean ± SD)

6.44 ± 5.0

6.5 ± 5.8

NS

Mean # of 2PN/ # of oocytes retrieved (mean ± SD)

0.69 ± 0.2

0.63 ± 0.2

NS

Mean # of TQE per OPU (mean ± SD)

2.8 ± 2.7

2.8 ± 3.3

NS

Mean # of TQE/ # of 2PN(mean ± SD)

0.40 ± 0.3

0.40 ± 0.2

NS

Semen volume (mL) (mean ± SD)

3.0 ± 1.4

3.2 ± 1.7

NS

Sperm concentration (Millions)(mean ± SD)

72.4 ± 61.5

80.2 ± 55.7

NS

Sperm % motility (mean ± SD)

56 ± 22

54 ± 20

NS

Pre-wash total motile sperm count, millions (mean ± SD)

134 ± 169

146 ± 159

NS